Loading...
Market
What will be the percentage reduction in colorectal cancer cases reported in the US following increased aspirin use by December 31, 2025?
2
Resolution / Starting Odds
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Public health reports or cancer registry data
Story
Harvard Study: Daily Aspirin Use Reduces Colorectal Cancer Risk by a Third
Aug 1, 2024, 03:15 PM
A major study has found that regular use of aspirin can significantly reduce the risk of developing colorectal cancer, even among individuals with unhealthy lifestyles. The study, conducted by researchers at Harvard and MassGenBrigham and published in JAMA Oncology, indicates that taking aspirin daily may reduce the risk of colon cancer by up to a third. This protective effect is believed to be due to aspirin's ability to block polyps, which are precursors to cancer. The findings offer hope for preventing colorectal cancer, which is a growing epidemic.
View original story
Similar markets
Less than 10% • 25%
10% to 20% • 25%
21% to 30% • 25%
More than 30% • 25%
0-10% • 25%
11-20% • 25%
21-30% • 25%
More than 30% • 25%
Yes • 50%
No • 50%
Less than 30% • 25%
30% to 40% • 25%
41% to 50% • 25%
More than 50% • 25%
Less than 20% • 25%
20% to 30% • 25%
30% to 40% • 25%
More than 40% • 25%
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Below 40% • 25%
40% - 50% • 25%
50% - 60% • 25%
Above 60% • 25%
Less than 10 states • 25%
10 to 20 states • 25%
21 to 30 states • 25%
More than 30 states • 25%